Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Repligen Corp
ISIN US7599161095
|WKN 870980
Market cap (in EUR)
6,256 m
Country
United States
Sector
Healthcare
Dividend yield
0.00%
Overview
Description
Repligen Corp. is a global life sciences company, which engages in providing bioprocessing technologies and solutions used in the process of manufacturing biological drugs. It operates through the North America. Europe, and Asia Pacific Region or Other geographical segments. The company was founded by Alexander G. Rich and Paul R. Schimmel in May 1981 and is headquartered in Waltham, MA.
Healthcare Healthcare Services Miscellaneous Healthcare United States
Financials
Key metrics
| Market capitalisation, EUR | 6,256 m |
| EPS, EUR | 0.77 |
| P/B ratio | 3.5 |
| P/E ratio | 152.6 |
| Dividend yield | 0.00% |
Income statement (2025)
| Revenue, EUR | 654 m |
| Net income, EUR | 43 m |
| Profit margin | 6.62% |
What ETF is Repligen Corp in?
There are 3 ETFs which contain Repligen Corp. All of these ETFs are listed in the table below. The ETF with the largest weighting of Repligen Corp is the JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist).
| ETF | Weight | Investment focus | Fund size (in m EUR) |
|---|---|---|---|
| Vanguard ESG Global All Cap UCITS ETF (USD) Distributing | 0.01% | Equity World Social/Environmental | 501 |
| Vanguard ESG North America All Cap UCITS ETF (USD) Distributing | 0.01% | Equity North America Social/Environmental | 25 |
| JPMorgan BetaBuilders US Small Cap Equity UCITS ETF USD (dist) | 0.10% | Equity United States Small Cap | 203 |
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.